Related Experiment Video
Updated: Aug 22, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study
Takashi Kudo1, Ryan Lahey2, Cole B Hirschfeld3
1Department of Radioisotope Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Insights
The COVID-19 pandemic significantly reduced cardiovascular diagnostic procedures in Asia, especially in low-income nations. Procedure volumes saw an 81% drop in these areas, highlighting disparities in care access during the health crisis.
Area of Science:
- Cardiology
- Public Health
- Infectious Diseases
Background:
- The COVID-19 pandemic profoundly impacted global cardiovascular disease management.
- The specific effects on the volume of cardiovascular diagnostic procedures remained unclear.
Purpose of the Study:
- To assess the early impact of the COVID-19 pandemic on cardiovascular diagnostic procedures in Asia.
- To evaluate changes in safety practices related to these procedures during the pandemic.
Main Methods:
- A worldwide survey was conducted by the International Atomic Energy Agency.
- Data on cardiovascular procedure volumes from March 2019, March 2020, and April 2020 were collected from 180 centers across 33 Asian countries.
- Data were analyzed by subregions to compare procedural volumes and safety practice changes.
Main Results:
- Cardiovascular procedure volumes decreased by 47% from March 2019 to March 2020.
- Eastern Asia, particularly China, showed recovery from March 2020 to April 2020.
- Lower-income countries experienced the most severe reductions, with an 81% decrease in volumes from March 2019 to April 2020.
- Centers implemented physical distancing, visitor restrictions, and increased study times; COVID-19 testing was infrequent.
Conclusions:
- The COVID-19 pandemic led to substantial reductions in cardiovascular diagnostic procedures across Asia, with a disproportionate impact on low-income countries.
- Further research is needed to understand the long-term cardiovascular outcomes and evolving care delivery models post-pandemic.
Background:
The coronavirus disease-2019 (COVID-19) pandemic significantly affected management of cardiovascular disease around the world. The effect of the pandemic on volume of cardiovascular diagnostic procedures is not known.
Objectives:
This study sought to evaluate the effects of the early phase of the COVID-19 pandemic on cardiovascular diagnostic procedures and safety practices in Asia.
Methods:
The International Atomic Energy Agency conducted a worldwide survey to assess changes in cardiovascular procedure volume and safety practices caused by COVID-19. Testing volumes were reported for March 2020 and April 2020 and were compared to those from March 2019. Data from 180 centers across 33 Asian countries were grouped into 4 subregions for comparison.
Results:
Procedure volumes decreased by 47% from March 2019 to March 2020, showing recovery from March 2020 to April 2020 in Eastern Asia, particularly in China. The majority of centers cancelled outpatient activities and increased time per study. Practice changes included implementing physical distancing and restricting visitors. Although COVID testing was not commonly performed, it was conducted in one-third of facilities in Eastern Asia. The most severe reductions in procedure volumes were observed in lower-income countries, where volumes decreased 81% from March 2019 to April 2020.
Conclusions:
The COVID-19 pandemic in Asia caused significant reductions in cardiovascular diagnostic procedures, particularly in low-income countries. Further studies on effects of COVID-19 on cardiovascular outcomes and changes in care delivery are warranted.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

